Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms.

Exact low-resolution brain electromagnetic source tomography (eLORETA) Mild cognitive impairment (MCI) Prodromal and overt dementia with Lewy bodies (DLB) Rapid eye movement sleep behavior disorders (RBD) Resting state electroencephalographic (EEG) rhythms Visual hallucinations

Journal

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
ISSN: 1872-8952
Titre abrégé: Clin Neurophysiol
Pays: Netherlands
ID NLM: 100883319

Informations de publication

Date de publication:
11 2020
Historique:
received: 03 07 2019
revised: 29 06 2020
accepted: 07 09 2020
pubmed: 12 10 2020
medline: 26 5 2021
entrez: 11 10 2020
Statut: ppublish

Résumé

Here we tested if cortical sources of resting state electroencephalographic (rsEEG) rhythms may differ in sub-groups of patients with prodromal and overt dementia with Lewy bodies (DLB) as a function of relevant clinical symptoms. We extracted clinical, demographic and rsEEG datasets in matched DLB patients (N = 60) and control Alzheimer's disease (AD, N = 60) and healthy elderly (Nold, N = 60) seniors from our international database. The eLORETA freeware was used to estimate cortical rsEEG sources. As compared to the Nold group, the DLB and AD groups generally exhibited greater spatially distributed delta source activities (DLB > AD) and lower alpha source activities posteriorly (AD > DLB). As compared to the DLB "controls", the DLB patients with (1) rapid eye movement (REM) sleep behavior disorders showed lower central alpha source activities (p < 0.005); (2) greater cognitive deficits exhibited higher parietal and central theta source activities as well as higher central, parietal, and occipital alpha source activities (p < 0.01); (3) visual hallucinations pointed to greater parietal delta source activities (p < 0.005). Relevant clinical features were associated with abnormalities in spatial and frequency features of rsEEG source activities in DLB patients. Those features may be used as neurophysiological surrogate endpoints of clinical symptoms in DLB patients in future cross-validation prospective studies.

Identifiants

pubmed: 33039748
pii: S1388-2457(20)30475-2
doi: 10.1016/j.clinph.2020.09.004
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2716-2731

Informations de copyright

Copyright © 2020 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Maria Teresa Pascarelli (MT)

Oasi Research Institute - IRCCS, Troina, Italy.

Claudio Del Percio (C)

Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.

Maria Francesca De Pandis (MF)

San Raffaele of Cassino, Cassino, FR, Italy.

Raffaele Ferri (R)

Oasi Research Institute - IRCCS, Troina, Italy.

Roberta Lizio (R)

IRCCS SDN, Napoli, Italy.

Giuseppe Noce (G)

IRCCS SDN, Napoli, Italy.

Susanna Lopez (S)

Department of Emergency and Organ Transplantation - Nephrology, Dialysis and Transplantation Unit, Aldo Moro University of Bari, Bari, Italy.

Marco Rizzo (M)

Oasi Research Institute - IRCCS, Troina, Italy.

Andrea Soricelli (A)

IRCCS SDN, Napoli, Italy; Department of Motor Sciences and Healthiness, University of Naples Parthenope, Naples, Italy.

Flavio Nobili (F)

Clinica neurologica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Dipartimento di Neuroscienze, Oftalmologia, Genetica, Riabilitazione e Scienze Materno-infantili (DiNOGMI), Università di Genova, Italy.

Dario Arnaldi (D)

Clinica neurologica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Dipartimento di Neuroscienze, Oftalmologia, Genetica, Riabilitazione e Scienze Materno-infantili (DiNOGMI), Università di Genova, Italy.

Francesco Famà (F)

Dipartimento di Neuroscienze, Oftalmologia, Genetica, Riabilitazione e Scienze Materno-infantili (DiNOGMI), Università di Genova, Italy.

Francesco Orzi (F)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Carla Buttinelli (C)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Franco Giubilei (F)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Marco Salvetti (M)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy; Neuromed: IRCCS Istituto Neurologico Mediterraneo (INM) Neuromed, 86077 Pozzilli, IS, Italy.

Virginia Cipollini (V)

Department of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.

Raffaella Franciotti (R)

Department of Neuroscience Imaging and Clinical Sciences and CESI, University G d'Annunzio of Chieti-Pescara, Chieti, Italy.

Marco Onofri (M)

Department of Neuroscience Imaging and Clinical Sciences and CESI, University G d'Annunzio of Chieti-Pescara, Chieti, Italy.

Peter Fuhr (P)

Universitätsspital Basel, Abteilung Neurophysiologie, Petersgraben 4, 4031 Basel, Switzerland.

Ute Gschwandtner (U)

Universitätsspital Basel, Abteilung Neurophysiologie, Petersgraben 4, 4031 Basel, Switzerland.

Gerhard Ransmayr (G)

Department of Neurology 2, Med Campus III, Faculty of Medicine, Johannes Kepler University, Kepler University Hospital, Krankenhausstr. 9, A-4020 Linz, Austria.

Dag Aarsland (D)

Department of Old Age Psychiatry, King's College University, London, UK.

Lucilla Parnetti (L)

Centre for Memory Disturbances, Lab of Clinical Neurochemistry, Section of Neurology, University of Perugia, Italy.

Lucia Farotti (L)

Centre for Memory Disturbances, Lab of Clinical Neurochemistry, Section of Neurology, University of Perugia, Italy.

Moira Marizzoni (M)

Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.

Fabrizia D'Antonio (F)

Department of Human Neurosciences, Sapienza University of Rome, Italy.

Carlo De Lena (C)

Department of Human Neurosciences, Sapienza University of Rome, Italy.

Bahar Güntekin (B)

Department of Biophysics, International School of Medicine, Istanbul Medipol University, Istanbul, Turkey.

Lutfu Hanoğlu (L)

Department of Neurology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.

Görsev Yener (G)

Izmir Biomedicine and Genome Center, Dokuz Eylul University Health Campus, Izmir, Turkey; Department of Neurosciences, Institute of Health Sciences, Dokuz Eylul University, Izmir, Turkey.

Derya Durusu Emek-Savaş (DD)

Department of Psychology and Department of Neurosciences, Dokuz Eylül University, Izmir, Turkey.

Antonio Ivano Triggiani (AI)

Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

John Paul Taylor (J)

Institute of Neuroscience, Newcastle University, Newcastle, UK.

Ian McKeith (I)

Institute of Neuroscience, Newcastle University, Newcastle, UK.

Fabrizio Stocchi (F)

Institute for Research and Medical Care, IRCCS San Raffaele Pisana, Rome, Italy.

Laura Vacca (L)

Institute for Research and Medical Care, IRCCS San Raffaele Pisana, Rome, Italy.

Harald Hampel (H)

Department of Neurology, Institute of Memory and Alzheimer's Disease (IM2A), Brain and Spine Institute (ICM), François Lhermitte Building, France.

Giovanni B Frisoni (GB)

Laboratory of Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy; Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Geneva, Switzerland.

Laura Bonanni (L)

Department of Neuroscience Imaging and Clinical Sciences and CESI, University G d'Annunzio of Chieti-Pescara, Chieti, Italy.

Claudio Babiloni (C)

Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy; San Raffaele of Cassino, Cassino, FR, Italy. Electronic address: claudio.babiloni@uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH